This article will cover the similarities and differences between Farxiga and Jardiance, including their uses, side effects, ...

AstraZeneca’s Farxiga has become the latest type 2 diabetes drug to show it can reduce cardiovascular risk in a clinical trial. Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin ...

Hope that AstraZeneca's diabetes and heart failure drug Farxiga might treat patients ... including the UK – as a link to thrombotic side effects is investigated. The drugmaker is also developing ...